Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 223-151-6 | CAS number: 3749-87-9
Endpoint summary
Administrative data
Description of key information
The predicted oral LD50 in rats is 2800 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 800 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
A predicted oral LD50in rats value is available (LD50: 2800 mg/kg bw). No values are available for inhalation and dermal routes, and no experimental values have been produced, because not necessary, considering that exposure by these routes is not significant and unlikely. A subcutaneous LD50in rabbits is available in literature for the similar substance ursodeoxycholic acid and according to this value (LD50: > 2000 mg/kg bw) it can be supposed that acute dermal toxicity will be low.
Justification for selection of acute toxicity – inhalation endpoint
No experimental data was deemed necessary for inhalation route, because the substance is for professional use only and, at the workplace, suitable respiratory personal protective equipment are adopted in order to avoid workers exposure. Therefore no exposure is expected by inhalation route.
Justification for selection of acute toxicity – dermal endpoint
No experimental data was deemed necessary for dermal route, because the substance is for professional use only and, at the workplace, suitable personal protective equipment are adopted in order to avoid workers exposure. Moreover, no dermal toxicity is expected on the basis of the available data on subcutaneous acute toxicity in rabbits (LD50 > 2000 mg/kg bw), basing on a read-across approach.
Justification for classification or non-classification
In conclusion, basing on the available toxicological information, no classification for acute toxicity by oral, inhalation and dermal routes is deemed necessary for methyl 3-α,7-α-diacetoxy-12-α-hydroxy-5-β-cholan-24-oate, according to Regulation 1272/2008/EU.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
